HopeStage
Back to all studies
TerminatedEUCTR 2010-020467-21

Estudio en fase III multicéntrico aleatorizado, de 24 semanas, doble ciego, de grupos paralelos y controlado con placebo para evaluar la eficacia y la seguridad de RO4917838 en pacientes estables c...

This historical record does not confirm current site availability.

Historical research recordMultiple countriesSchizophrenia
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Germany · Latvia and 4 more locations
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Terminated
Enrollment listed in the registry
620
Sponsor
F. Hoffmann-La Roche Ltd
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Germany, Latvia, Lithuania, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2010-020467-21
Official title
Show the full official title

Estudio en fase III multicéntrico aleatorizado, de 24 semanas, doble ciego, de grupos paralelos y controlado con placebo para evaluar la eficacia y la seguridad de RO4917838 en pacientes estables c...

Recruitment & locations

Terminated

Germany · Latvia · Lithuania

3 more locations
  • Netherlands
  • Slovakia
  • Spain
Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is F. Hoffmann-La Roche Ltd.

Is this study still recruiting?

The historical registry lists this study as terminated.

Want to explore more studies?

Explore studies